Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1
Joseph H. Chan, George A. Freeman, Jeffrey H. Tidwell et al. · Journal of Medicinal Chemistry · 2004
GW4511, GW4751, and GW3011 showed IC50 values < or =2 nM against wild type HIV-1 and <10 nM against 16 mutants. They were particularly potent against NNRTI-resistant viruses containing Y181C-, K103N-, and K103N-based double mutations, which account for a significant proportion of the clinical failure of the three currently marketed NNRTIs. The antiviral data together with the favorable pharmacokinetic data of GW4511 suggested that these benzophenones possess attributes of a new NNRTI drug candidate.
Cited by 65 works. doi:10.1021/jm030255y
Authors
- Joseph H. Chan
- George A. Freeman
- Jeffrey H. Tidwell
- Karen R. Romines
- Lee T. Schaller
- Jill R. Cowan
- Steve S. Gonzales
- Gina S. Lowell
- C. Webster Andrews
- David J. Reynolds
- Marty St. Clair
- Richard J. Hazen
- Rob G. Ferris
- Katrina L. Creech
- Grace B. Roberts
- Steven A. Short
- Kurt L. Weaver
- George W. Koszalka
- Lawrence R. Boone
References
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
- L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
- Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates
- Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients
- 11th Conference on Retroviruses and Opportunistic Infections
- Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260)
- Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutions
- Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase